This application seeks to develop a pre- and postdoctoral training program centered on neuromuscular biology and associated diseases including Duchenne muscular dystrophy, spinal muscular atrophy, and amyotrophic lateral sclerosis that together affect approximately 80,000 people in the United States. Although the neuromuscular field has made tremendous strides in better understanding the underlying mechanisms of these disorders, which in some cases have translated to new treatment options, greater research is needed to discover cures for these terminal diseases, since sadly currently none exist. Achieving this goal hinges on the quality of research laboratories and clinics worldwide, and importantly, on the success of training programs that will prepare the next generation of graduate students along with basic and clinical postdoctoral researchers to continue making fundamental strides in ascertaining the causes and cures of neuromuscular diseases. The laboratories of Ohio State University and Nationwide Children's Hospital consist of 16 mentors that have significant basic and translational expertise in neuromuscular research. This group of mentors and their laboratories are highly interactive, and working together has generated a research environment that is also highly conducive to the success of their predoctoral and postdoctoral trainees. The foundation of this research environment comes from a larger working group of investigators vested in muscle and neurological research called the OSU/Children's Muscle Group, which for the past five years have closely interacted and successfully collaborated on impact publications and federally sponsored projects. These interactions were developed from holding monthly scientific meetings and annual trainee poster symposiums, organizing a regional scientific conference, and initiating a multi-laboratory journal club. The early successes from establishing this working research group have translated to receiving institutional support that we have used to further establish our training program. With the commitments of our faculty and university, along with existing supporting training programs from the Wellstone Muscular Dystrophy Cooperative Research Center, our core 16 mentors have developed a more structured training plan, which is the basis of this application. The training, specialized in neuromuscular diseases, will contain three tracks, one for graduate students, a second for basic postdoctoral scientists, and a third for clinical postdoctoral scientists. Each will contain a unique training component that will ensure that predoctoral and postdoctoral fellows are well positioned to transition to the next phase of their careers, and importantly, are able to contribute to the future discoveries underlying the causes and cures of neuromuscular diseases.
|Nixon, Benjamin R; Walton, Shane D; Zhang, Bo et al. (2014) Combined troponin I Ser-150 and Ser-23/24 phosphorylation sustains thin filament Ca(2+) sensitivity and accelerates deactivation in an acidic environment. J Mol Cell Cardiol 72:177-85|
|Frakes, Ashley E; Ferraiuolo, Laura; Haidet-Phillips, Amanda M et al. (2014) Microglia induce motor neuron death via the classical NF-?B pathway in amyotrophic lateral sclerosis. Neuron 81:1009-23|
|Gombash Lampe, Sara E; Kaspar, Brian K; Foust, Kevin D (2014) Intravenous injections in neonatal mice. J Vis Exp :e52037|
|Nixon, Benjamin R; Liu, Bin; Scellini, Beatrice et al. (2013) Tropomyosin Ser-283 pseudo-phosphorylation slows myofibril relaxation. Arch Biochem Biophys 535:30-8|